News &amp; Updates

Lidocaine-filled dilators may minimize pain during IUD removal

Infusing lidocaine into a disposable injectable cervical dilator helps reduce pain during the removal of an intrauterine device (IUD), especially when intrauterine manipulations are needed, according to a study.

Lidocaine-filled dilators may minimize pain during IUD removal

Gastric fundus ablation targets hunger hormone for weight loss

08 Jun 2024 by

Ablating the gastric fundus to reduce the production of the hunger hormone ghrelin helps women curb their appetite and lose body weight in the ABLATE-WEIGHT first-in-human trial.

Gastric fundus ablation targets hunger hormone for weight loss

High cognitive reserve may counter dementia risk

High cognitive reserve appears to confer protection against dementia, even among people with genetic predisposition to dementia, according to a study.

High cognitive reserve may counter dementia risk

07 Jun 2024

Does adjuvant chemotherapy improve survival in stage II colon cancer?

In patients with stage II colon cancer, individuals with a right-sided colon cancer (RSCC) appear to have a better prognosis than those with a left-sided colon cancer (LSCC), reveals a recent study. Additionally, adjuvant chemotherapy (ACT) falls short of improving cause-specific survival (CSS) in patients with either RSCC or LSCC.

Does adjuvant chemotherapy improve survival in stage II colon cancer?

Bariatric surgery helps improve outcomes in IBD

Bariatric surgery (BS), particularly sleeve gastrectomy, contributes to the improvement of disease-specific outcomes in patients with inflammatory bowel disease (IBD) and obesity, reports a study.

Bariatric surgery helps improve outcomes in IBD

07 Jun 2024

ART discontinuation tied to toxicity, disease progression in mCRPC patients

Several patients with metastatic castration-resistant prostate cancer (mCRPC) discontinue the use of androgen receptor‒targeted therapies (ARTs) because of disease progression, while a few stopped ARTs due to treatment toxicity, according to a study.

ART discontinuation tied to toxicity, disease progression in mCRPC patients

07 Jun 2024

Atrasentan a new player in the IgAN treatment field?

In the prespecified interim analysis of the phase III ALIGN study, the investigational drug atrasentan shows promising signals when added to standard supportive care with a renin-angiotensin system (RAS) inhibitor in patients with IgA nephropathy (IgAN).

Atrasentan a new player in the IgAN treatment field?

Increased practice of Chinese calligraphy strengthens brain network in older adults

Increased practice of Chinese calligraphy strengthens brain network in older individuals who already practice the cognitive activity regularly and experienced subjective cognitive decline (SCD), a two-arm, parallel-design, assessor-blind, randomized controlled trial conducted by the Chinese University of Hong Kong (CUHK) has found.

Increased practice of Chinese calligraphy strengthens brain network in older adults

Newer glucose-lowering drugs best sulfonylureas, glinides in second-line treatment of T2D

Glucose-lowering drugs such as the glucagon-like peptide-1 receptor agonist (GLP-1-RA), sodium-glucose cotransporter 2 inhibitor (SGLT2i), and dipeptidyl peptidase-4 inhibitor (DPP-4i) work better and are more cost-effective than sulfonylureas and glinides (SU) as second-line treatment for type 2 diabetes (T2D), according to a population-based retrospective cohort study.

Newer glucose-lowering drugs best sulfonylureas, glinides in second-line treatment of T2D